Contact
Please use this form to send email to PR contact of this press release:
Merck Statement on FDA Advisory Committee Meeting on IMPROVE-IT Study with VYTORIN® (ezetimibe and simvastatin)
TO:
Please use this form to send email to PR contact of this press release:
Merck Statement on FDA Advisory Committee Meeting on IMPROVE-IT Study with VYTORIN® (ezetimibe and simvastatin)
TO: